Source Multiple Sclerosis News Today: Multiple sclerosis (MS) experts in the United Kingdom have proposed consensus guidelines for the management and treatment of pregnant women with the disease, and couples affected by MS who are planning a pregnancy. The new guidelines are expected to reduce uncertainty about treatments that are considered to be safe and… Read more »
Posts Categorized: MS News
Disease modifying drugs may reduce risk of secondary progressive MS
MS Newsletter Jan – Mar 2019
Registered Charity Nos 1139257/SC041990 Registered as a limited company in England and Wales 07451571 Dear Friends The weather couldn’t have beenworse. We held our collection at Millets Farm at Frilford Heath on a December day which was bitterly cold and, for most of the time, pelting with rain. Thankfully, the garden centre management broke the… Read more »
The Government has changed the law to make cannabis for medicinal use legal under prescription.
Source MS Society: The Government has today changed the law to make cannabis for medicinal use legal under prescription. But it’s likely that nothing will change in the short term for the one in 10 people with MS who could get relief from pain and muscle spasms by using medicinal cannabis. We’re calling for the… Read more »
NICE pauses final decision on ocrelizumab for primary progressive MS
Source MS Trust: NICE has announced that it is pausing the publication of final guidance for ocrelizumab for primary progressive multiple sclerosis. The final decision was due to be published on the NICE website on 31 October and would have rejected ocrelizumab as an NHS treatment for primary progressive MS on the grounds of cost-effectiveness. The MS Trust now understands that… Read more »
Novartis bets priority review voucher on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Source Endpoints News: One of Novartis’ top late-stage candidates for multiple sclerosis is now under review on both sides of the Atlantic. Having stoked enthusiasm for siponimod through a solid Phase III data package, the Swiss drugmaker traded in a priority review voucher at the FDA for an expedited action date around March of next year…. Read more »
Former watchdog chief labels disabled benefits process a ‘hostile environment’
Source The Guardian: Andrew McDonald, who chaired Independent Parliamentary Standards Authority, says the system is ‘Kafka-esque’ A former top civil servant has criticised the disability benefits assessment system as a “hostile environment” after being told he was ineligible for support despite having Parkinson’s and terminal prostate cancer. Andrew McDonald, 56, who ran the parliamentary body overseeing… Read more »
Medical Cannabis To Be Available On Prescription ‘Within Weeks’
Source Huffington Post: Medical cannabis will be available on prescription in the UK within a month, according to The Telegraph. The Home Office is expected to announce the “rescheduling” of cannabis-derived medicines in Parliament within a fortnight, lifting restrictions which mean that until now it has only been allowed in the most exceptional circumstances within a matter… Read more »
Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
Source Neurology Advisor: Increased levels of physical activity may lead to decreased vascular risk profiles in patients with multiple sclerosis, according to a literature review published in Multiple Sclerosis and Related Disorders. Researchers in this review searched for published articles in 5 major databases for studies involving physical activity, sedentary lifestyles, or exercise training and the impact these… Read more »
“Diagnose and adios”. This was the phrase used to describe the management of multiple sclerosis (MS) up until the mid-1990s
Source MS Trust: The Risk Sharing Scheme: What is it and how has it made a difference for people with MS? Diagnose and adios “Diagnose and adios”. This was the phrase used to describe the management of multiple sclerosis (MS) up until the mid-1990s. It’s hard to fathom today, but back then neurologists had little to… Read more »